Surprisingly, SOCS3 protein levels were already significantly increased at the pre-symptomatic stage as early as 9 weeks old as examined, indicating that the ongoing neuroinflammation already started during the preclinical phase of the disease and preceded the ALS progression. Here, SOCS3 is linked to amyotrophic lateral sclerosis.